In search of a role for the morphine metabolite morphine-3-glucuronide.
Vaughan
C W
CW
*Pain Management Research Institute, Northern Clinical School, University of Sydney, New South Wales, Australia, and †Vollum Institute, Oregon Health & Sciences University, Portland, Oregon.
Connor
M
M
D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009020:Morphine / Q000009:adverse effects* / Q000378:metabolism; D009022:Morphine Derivatives / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D051381:Rats
D000701:Analgesics, Opioid; D000697:Central Nervous System Stimulants; D009022:Morphine Derivatives; D009020:Morphine; C018108:morphine-3-glucuronide; D002118:Calcium